A ramdomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: An Eastern Cooperative Oncology Group study (E3486)

Leukemia and Lymphoma

Volumn 44, Issue 9, 2003, Pages 1515-1521

  Wiernik, Peter H ^a   Cassileth, Peter A ^b   Leong, Traci ^c,g   Hoagland, H Clark ^d   Bennett, John M ^e   Paietta, Elisabeth ^a   Oken, Martin M ^f  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d MAYO CLINIC CANCER CENTER   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f Center for Immunology   (United States)

^g EMORY UNIVERSITY   (United States)

Author keywords

Acute lymphoblastic leukemia; Adult ALL; ALL; ECOG group study; Randomized trial

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; FOLINATE CALCIUM; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE; ANTINEOPLASTIC AGENT; DATOP PROTOCOL; DVP (DAUNOMYCIN); MACHO PROTOCOL; PREDNISOLONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BLEEDING; BONE MARROW SUPPRESSION; CANCER REGRESSION; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG INFUSION; DRUG RESPONSE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HUMAN; INFECTION; LIVER TOXICITY; MALE; NEPHROTOXICITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN MANIFESTATION; TIME; TREATMENT OUTCOME; ACUTE LYMPHOCYTIC LEUKEMIA; AGED; COMPARATIVE STUDY; DRUG ADMINISTRATION; LIFE TABLE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; REMISSION; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; LIFE TABLES; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; PREDNISONE; REMISSION INDUCTION; SURVIVAL ANALYSIS; THIOGUANINE; TREATMENT OUTCOME; VINCRISTINE;

EID: 0038235850     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000082975     Document Type: Article

References (23)

1. Esterhay, Jr., R.J., Wiernik, P.H., Grove, W.R., et al. (1982) "Moderate dose methotrexate, vincristine, asparaginase, and dexamethasone for treatement of adult acute lymphocytic leukemia", Blood 59, 334-345.
2. Kantarjian, H.M., O'Brien, S., Smith, T.L., et al. (2000) "Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia", J. Clin. Oncol. 18, 547-561.
3. Durrant, I.J., Richards, S.M., Prentice, H.G. and Goldstone, A.H. (2000) "The Medical Research Council trials in adult acute lymphocytic leukemia", Hematol. Oncol. Clin. N. Am. 14, 1327-1352.
4. Petersdorf, S.H., Kpoecky, K.J., Head, D.R., et al. (2001) "Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group study", Leukemia 15, 208-216.
5. Thomas, X., Danaila, C., Le, Q.-H., et al. (2001) "Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period", Leukemia 15, 1811-1822.
6. Wiernik, P.H., Dutcher, J.P., Paietta, E., et al. (1993) "Long-term follow-up of treatment and potential cure of adult acute lymphocytic leukemia with MOAD: a non-anthrcycline containing regimen", Leukemia 7, 1236-1241.
7. Linker, C.A., Levitt, L.J., O'Donnell, M., et al. (1991) "Treatment of adult lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report", Blood 78, 2814-2822.
8. Cassileth, P.A., Andersen, J.W., Bennett, J.M., et al. (1992) "Adult acute lymphoblastic leukemia: the Eastern Cooperative Oncology Group experience", Leukemia 6(Suppl. 2), 178-181.
9. Cassileth, P.A., Andersen, J.W., Hoagland, H.C., et al. (1989) Acute Lymphoblastic Leukemia (Alan R. Liss, New York), p 197.
10. Mehta, C.R. and Patel, N.R. (1983) "A network algorithm for performing Fisher's exact test in r × c contingency tables", J. Am. Stat. Assoc. 78, 427-434.
11. Kaplan, E.L. and Meier, P. (1958) "Nonparametric estimation from incomplete observation", J. Am. Stat. Assoc. 53, 457-481.
12. Peto, R. and Peto, J. (1972) "Asymptotically efficient rank invariant test procedures (with discussion)", J. R. Stat. Soc. A135, 185-206.
13. Goldstone, A.H., Burnett, A.K., Wheatley, K., et al. (2001) "Attempts to improve outcome in acute myeloid leukemia (AML) in older patients: the result of the United Kingdom Medical Research Council AML 11 trial", Blood 98, 1302-1311.
14. Hunault-Berger, M., Milpied, N., Bernard, M., et al. (2001) "Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study", Leukemia 15, 898-902.
15. Mayer, R.J., Davis, R.B., Schiffer, C.A., et al. (1994) "Intensive postremission therapy in adults with acute myeloid leukemia", N. Engl. J. Med. 331, 896-903.
16. Weiss, M., Telford, P., Kempin, S., et al. (1993) "Severe toxicity limits intensification of induction therapy for acute lymphoblastic leukemia", Leukemia 7, 832-837.
17. Gokbuget, N., Hoelzer, D., Arnold, R., et al. (2000) "Treatment of adult ALL according to protocols of the German Multicenter Study Group for adult ALL (GMALL)", Hematol. Oncol. Clin. N. Am. 14, 1307-1325.
18. Ellison, R.R., Mick, R., Cuttner, J., et al. (1991) "The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trail by Cancer and Leukemia Group B", J. Clin. Oncol. 9, 2002-2015.
19. Lanker, C., Damon, L. and Navarro, W. (2002) "Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia", J. Clin. Oncol. 20, 2464-2471.
20. Dekker, A.W., van't Veer, M.B., Sizoo, W., et al. (1997) "Intensive postremission chemotherapy without maintenance therapy in adults with acute lymphoblastic leukemia", J. Clin. Oncol. 15, 476-482.
21. Micallef, I.N., Rohatiner, A.Z., Carter, M., et al. (2001) "Long-term outcome of patients surviving for more than ten years following treatment for acute leukemia", Br. J. Haematol. 113, 443-445.
22. Annino, L., Vegna, M.L., Camera, A., et al. (2002) "Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study", Blood 99, 863-871.
23. Schrappe, M., Reiter, A., Ludwig, W.-D., et al. (2000) "Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90", Blood 95, 3310-3322.